---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-034726"
form_type: "8-K"
ticker: "IMAX"
cik: "0000921582"
company_name: "IMAX CORP"
filed_at: "2023-07-26T23:59:59+00:00"
generated_at: "2026-06-13T02:38:28.085759+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "medium"
source: SEC EDGAR
---

# IMAX Q2 2023 revenue up 32% YoY; signs 84 systems YTD vs 47 in all 2022

## Summary
- Revenue +32% YoY; gross margin +31%; adjusted EBITDA +29% (non-GAAP).
- System signings YTD 84 (vs 47 in all 2022); installations 29 through June.
- IMAX global box office share record 20% with 'Oppenheimer' $35M debut.
- Cash from operations $25.9M in H1 2023 vs -$5.3M use in H1 2022.

## SEC filing metadata
- accession: 0000950170-23-034726
- form_type: 8-K
- ticker: IMAX
- cik: 0000921582
- company_name: IMAX CORP
- filed_at: 2023-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921582/000095017023034726/0000950170-23-034726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921582/000095017023034726/imax-20230726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-034726
- JSON: https://secwatch.observer/filing/0000950170-23-034726.json
- Plain text: https://secwatch.observer/filing/0000950170-23-034726.txt

## Key facts
- Earnings Releases
  IMAX CORP reported financial results for the second quarter of 2023.
  - Period: the second quarter of 2023
  - Result: reported results
  source text: On July 26, 2023, IMAX Corporation (the “Company”) issued a press release announcing the Company’s financial and operating results for the quarter ended June 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/921582/000095017023034726/0000950170-23-034726-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.